4.7 Review

State-of-the-art in ligand-based virtual screening

Journal

DRUG DISCOVERY TODAY
Volume 16, Issue 9-10, Pages 372-376

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2011.02.011

Keywords

-

Funding

  1. Deutsche Forschungsgemeinschaft [GRK804]
  2. Bayer Healthcare AG, Wuppertal

Ask authors/readers for more resources

Virtual screening is a much discussed topic in chemoinformatics and medicinal chemistry, and widely applied in pharmaceutical research. Here, we provide an in-depth analysis of currently available ligand-based virtual screening applications. We formulate several scientific quality criteria for prospective ligand-based virtual screens and analyze, in detail, the information provided by currently available peer-reviewed publications. The results presented herein provide a detailed view of the current state-of-the-art in this field and point at several problematic issues but also opportunities for further advances.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available